Abstract
Bacterial diseases cause high mortality in Penaeus (Litopenaeus) vannamei postlarvae. Therefore, appropriate application of efficient therapeutic products is of vital importance for disease control. This study evaluated through in vitro analyses the antimicrobial effectiveness of commercial therapeutic products used for P. vannamei bacterial diseases and antibiotics against pathogenic Vibrio strains circulating in Ecuadorian hatcheries. Twenty strains were isolated from 31 larvae samples with high bacterial counts from 10 hatcheries collected during mortality events. The strains virulence was verified through challenge tests with Artemia franciscana nauplii and P. vannamei postlarvae. Through 16S rRNA sequence analysis, strains showed a great similarity to the Vibrio sequences reported as pathogens, with 95% belonging to the Harveyi clade. Through antibiograms and minimal inhibitory concentration (MIC) in vitro tests we found that furazolidone, ciprofloxacin, chloramphenicol, norfloxacin, nalidixic acid, florfenicol, fosfomycin and enrofloxacin inhibited the growth of all or most of the strains. Less efficient antibiotics were penicillin, oxytetracycline and tetracycline. A multiple antibiotic resistance (MAR) index of 0.23 showed some level of resistance to antibiotics, with two MAR prevalent patterns (Penicillin-Oxytetracycline and Penicillin-Oxytetracycline-Tetracycline). From a total of 16 natural products (five probiotics, nine organic acids and two essential oils), only three (one probiotic, one organic acid and one essential oil) were effective to control most of the strains. Shrimp producers can apply relatively simple in vitro analyses, such as those employed in this study, to help take adequate management decisions to reduce the impact of bacterial diseases and increase profit.
Highlights
The high demand of postlarvae to support the cultured shrimp industry and the intensification at hatchery level, together with the trade of aquatic animals and their associated products, has increased the occurrence of infectious pathogens in this production stage [1]
The efficiency of therapeutic products is of vital importance for the control of aquaculture diseases
The administration of probiotics is one of the alternative strategies that may be used in aquaculture [13]; their benefits include the potential for colonization in the gastrointestinal tract, selective antagonism against bacterial pathogens, improvement of the shrimp immune system, enhanced shrimp growth and survival, degradation of detritus and maintenance of water quality [18,19,20]
Summary
The high demand of postlarvae to support the cultured shrimp industry and the intensification at hatchery level, together with the trade of aquatic animals and their associated products, has increased the occurrence of infectious pathogens in this production stage [1]. The use of antibiotics carries important disadvantages, these being residues in aquaculture products [14,15,16], development and propagation of resistance between pathogens, including human pathogens [17] For these reasons, the regulation of antibiotics is rigorously controlled, resulting in few antibiotics authorized for use in aquaculture. The use of organic acids, produced by organisms and used as preservatives and bacterial control in food, agriculture, and animal production, is another potential strategy to control bacterial diseases in animal production [21,22,23] They inhibit the growth of pathogenic V. harveyi, Vibrio cholera, V. alginolyticus, Vibrio parahaemolyticus and V. campbellii [24,25,26], exhibit immunostimulant properties [24, 27], and improve the nutritional and health state of shrimp [28, 29]. There are a huge number of products marketed as therapeutic products for shrimp hatcheries worldwide, producers should take suitable decisions as to which products are effective based on technical information and further tests in their own facilities
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have